G47.33

Obstructive sleep apnea (adult) (pediatric)

Obstructive Sleep Apnea (OSA), coded as G47.33 in ICD-10-CM, is a chronic and progressive sleep-related breathing disorder characterized by recurrent episodes of upper airway obstruction during sleep. These obstructions lead to a reduction or cessation of airflow despite ongoing respiratory effort, resulting in intermittent hypoxemia, hypercapnia, and fragmented sleep. The diagnosis applies to both adult and pediatric populations, though clinical presentation and underlying causes can vary. Pathophysiologically, OSA involves the collapse of the pharyngeal airway due to a combination of anatomical factors (e.g., enlarged tonsils/adenoids in children, obesity, retrognathia, large tongue, soft palate abnormalities) and neuromuscular dysfunction (reduced muscle tone in the upper airway during sleep). This collapse leads to apneic (complete cessation) or hypopneic (partial reduction) events, typically lasting 10 seconds or more in adults. Each event triggers an arousal from sleep, often unnoticed by the patient, to restore airway patency. The repeated cycles of hypoxia, hypercapnia, and sleep fragmentation exert significant physiological stress, contributing to a wide range of short-term and long-term health consequences. Untreated OSA is associated with substantial morbidity, including an increased risk of cardiovascular diseases such as hypertension, coronary artery disease, atrial fibrillation, stroke, and heart failure. Metabolic complications, including insulin resistance and type 2 diabetes, are also more prevalent. Neurocognitive impairments, such as impaired memory, concentration difficulties, and excessive daytime sleepiness, significantly impact quality of life, work productivity, and increase the risk of accidents (e.g., motor vehicle collisions). In children, OSA can manifest as behavioral problems, developmental delays, growth failure, and attention-deficit/hyperactivity disorder (ADHD)-like symptoms, often without the classic snoring observed in adults. Diagnosis typically involves an overnight polysomnography (PSG) or a home sleep apnea test (HSAT), which measures parameters like airflow, respiratory effort, oxygen saturation, and sleep stages to determine the Apnea-Hypopnea Index (AHI). Treatment strategies range from lifestyle modifications (weight loss, avoiding alcohol/sedatives) and positional therapy to continuous positive airway pressure (CPAP), oral appliances, and surgical interventions. Early diagnosis and appropriate management are crucial for mitigating the adverse health outcomes and improving patient well-being.

Clinical Symptoms

  • Loud, disruptive snoring
  • Witnessed breathing pauses during sleep
  • Gasping or choking during sleep
  • Excessive daytime sleepiness (EDS)
  • Morning headaches
  • Irritability and mood changes
  • Difficulty concentrating or memory problems
  • Nocturia (frequent nighttime urination)
  • Dry mouth or sore throat upon waking
  • Decreased libido
  • In children: hyperactivity, poor school performance, mouth breathing, bedwetting

Common Causes

  • Obesity (excess fat deposits around the upper airway)
  • Enlarged tonsils and adenoids (especially in children)
  • Craniofacial abnormalities (e.g., retrognathia, micrognathia)
  • Large neck circumference
  • Genetics (family history of OSA)
  • Male gender
  • Older age
  • Smoking
  • Alcohol and sedative use (relax upper airway muscles)
  • Hypothyroidism
  • Acromegaly
  • Nasal obstruction (e.g., deviated septum, allergies)

Documentation & Coding Tips

Document the specific type and severity of Obstructive Sleep Apnea (OSA), including whether it's adult or pediatric type. Utilize objective findings like Apnea-Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) from polysomnography results.

Example: Patient is a 58-year-old male with a documented history of severe Obstructive Sleep Apnea, adult type, confirmed by polysomnography in 2022 with an AHI of 42 events/hour. Patient continues to use CPAP nightly, noting improvement in daytime somnolence from severe (Epworth 16) to moderate (Epworth 9). Still experiences occasional witnessed apneas by spouse. This severe, adult-onset OSA is actively managed and contributes significantly to the patient's overall health burden, particularly given his co-morbid hypertension and Type 2 Diabetes.

Billing Focus: Specificity of 'severe' and 'adult type' directly supports higher complexity for E&M coding. Referencing objective AHI results substantiates the diagnosis and medical necessity for ongoing treatment. Documentation of symptom improvement (Epworth scores) demonstrates active management.

Explicitly link Obstructive Sleep Apnea to associated comorbidities and complications. Document the clinical impact of OSA on these conditions and vice versa.

Example: 34-year-old female presents with uncontrolled essential hypertension and new-onset atrial fibrillation, strongly suspected to be exacerbated by undiagnosed Obstructive Sleep Apnea. Patient reports chronic loud snoring, witnessed apneas, and debilitating daytime fatigue (Epworth 18). BMI 38. Plan: Refer to Sleep Medicine for polysomnography to diagnose Obstructive Sleep Apnea (pediatric type ruled out based on age) and initiate management. Emphasized the critical link between OSA, uncontrolled HTN, and AFib for her long-term cardiovascular health.

Billing Focus: Documenting the suspected or confirmed link between OSA and comorbidities (HTN, AFib) provides medical necessity for further diagnostic workup (polysomnography) and complex management strategies. It justifies higher E&M levels for managing multiple interacting chronic conditions.

Detail the current management plan for OSA, including adherence, efficacy, and any challenges. Document specific interventions, devices, or referrals.

Example: Established diagnosis of moderate Obstructive Sleep Apnea, adult type. Patient initiated CPAP therapy 3 months ago but reports inconsistent use (average 3-4 nights/week) due to mask discomfort. Polysomnography indicated AHI 22 events/hr. Discussed alternative mask types and the importance of consistent CPAP use for reducing cardiovascular risk and improving quality of life. Referred for follow-up with Sleep Medicine for CPAP optimization and consideration of oral appliance therapy due to persistent non-adherence. Counseling provided on lifestyle modifications including weight loss strategies (patient's BMI 32).

Billing Focus: Detailed documentation of management, patient adherence issues, and attempted solutions (e.g., CPAP optimization, referral for alternative therapies) supports ongoing E&M services. It clearly outlines the complexities of managing a chronic condition.

Relevant CPT Codes

Related Diagnoses

Hierarchy